USA financial news

Vapotherm to Report Second Quarter 2022 Monetary Outcomes | Information

EXETER, N.H.–(BUSINESS WIRE)–Jul 20, 2022–

Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Firm”), a world medical expertise firm targeted on the event and commercialization of its proprietary Vapotherm excessive velocity remedy ® merchandise that are used to deal with sufferers of all ages affected by respiratory misery, immediately introduced that it’ll launch monetary outcomes for the second quarter of 2022 after the shut of buying and selling on Wednesday, August 3, 2022. Vapotherm’s administration workforce will host a convention name starting at 4:30 p.m. ET to debate the monetary outcomes and up to date enterprise developments.

To hearken to the convention name in your phone, please dial (888) 330-2391 for U.S. callers, or +1 (240) 789-2702 for worldwide callers, roughly ten minutes previous to the beginning time and reference convention code 6585549. To hearken to a reside webcast, please go to the Buyers part of the Vapotherm web site at: http://traders.vapotherm.com/events-and-presentations/occasions. The webcast replay will likely be accessible on the Vapotherm web site for 90 days following completion of the decision. A replay of this convention name will likely be accessible by phone by way of August 10, 2022 by dialing (800) 770-2030 within the U.S. or +1 (647) 362-9199 outdoors of the U.S. The replay entry code is 6585549.

About Vapotherm

Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and producer of superior respiratory expertise primarily based in Exeter, New Hampshire, USA. The Firm develops progressive, snug, non-invasive applied sciences for respiratory assist of sufferers with power or acute respiratory problems. Over 3.5 million sufferers have been handled with using Vapotherm excessive velocity remedy® methods. For extra info, go to www.vapotherm.com.

Vapotherm excessive velocity remedy is mask-free non-invasive ventilatory assist and is a front-line software for relieving respiratory misery—together with hypercapnia, hypoxemia, and dyspnea. It permits for the quick, secure therapy of undifferentiated respiratory misery with one software. The Precision Stream system’s mask-free interface delivers optimally conditioned respiratory gases, making it snug for sufferers and lowering the dangers and care complexities related to masks therapies. Whereas being handled, sufferers can discuss, eat, drink and take oral remedy.

Web site Info

Vapotherm routinely posts necessary info for traders on the Investor Relations part of its web site, http://traders.vapotherm.com/. Vapotherm intends to make use of this web site as a way of exposing materials, personal info and for complying with Vapotherm’s disclosure obligations beneath Regulation FD. Accordingly, traders ought to monitor the Investor Relations part of Vapotherm’s web site, along with following Vapotherm’s press releases, Securities and Change Fee (“SEC”) filings, public convention calls, displays and webcasts. The knowledge contained on, or that could be accessed by way of, Vapotherm’s web site is just not integrated by reference into, and isn’t part of, this doc.

View supply model on businesswire.com:https://www.businesswire.com/information/residence/20220720005782/en/

CONTACT: Investor Relations Contact:

Mark Klausner or Mike Vallie, Westwicke, an ICR Firm,ir@vtherm.com, +1 (603) 658-0011

KEYWORD: UNITED STATES NORTH AMERICA NEW HAMPSHIRE

INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH MEDICAL DEVICES OTHER HEALTH HEALTH

SOURCE: Vapotherm, Inc.

Copyright Enterprise Wire 2022.

PUB: 07/20/2022 04:30 PM/DISC: 07/20/2022 04:32 PM

http://www.businesswire.com/information/residence/20220720005782/en

Copyright Enterprise Wire 2022.

Related posts

Overseas Secretary travels to USA

admin

A Week of Authorized Setbacks for Trump in Washington, New York | Washington, D.C. Information

admin

Russian economic system shudders after U.S. and Europe impose sanctions

admin